Domestic markets navigated a volatile week, ending near all-time highs. Bajaj Finance filed for a Rs 7,000 crore IPO, Kronox Lab to debut w...

For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.

Jubilant Pharmova Ltd. key Products/Revenue Segments include Organic Chemicals, Other Operating Revenue and Sale of services for the year e...

The crossing of the 50-day SMA by these companies reflects their resilience and potential for future growth, making them noteworthy contend...

As observed on July 28, 2023, stocks crossing their 50-day SMA have presented potential opportunities in various sectors, such as fintech, ...

Jubilant Pharmova's quarterly net loss widened to INR 98 crore in the March quarter of FY23 from a loss of INR 15.67 crore in the previous ...

The texture of the chart formation and technical indicators such as RSI is indicating at a likely reversal from the current levels, which c...

The entities belonging to the late Gautam Kulkarni family and part of the promoter group of Kirloskar Oil Engines Ltd have offloaded nearly...

Jubilant Pharmova, incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 6501.86 Crore) operating in Pharmaceutica...

Jubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 5304.06 Crore) operating in Pharmace...

Analysts have cut FY23 earning estimates by over 20 per cent. They see a near-term hangover in terms of margin and USFDA observations but s...

Analysts said near to medium term growth would remain under pressure due to regulatory issues, slow recovery in the API business and inflat...

Jubilant Pharmova announced that one of its subsidiaries received Abbreviated New Drug Application (ANDA) final approval for Doxepin Hydroc...

A few analysts believe revenues have bottomed out for drug maker Jubilant Pharmova, others do not hold high hopes in the short term

Jubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 11241.27 Crore) operating in Pharmac...

Jubilant Pharmova Ltd., incorporated in the year 1978, is a Mid Cap company (having a market cap of Rs 12593.56 Crore) operating in Pharmac...

Hospitals and pharmacists in major cities have reported acute shortage of the drug due to supply constraints and alleged hoarding.